12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25-50 mg/day) versus escitalopram (10-20 mg/day) in out-patients with severe generalized anxiety disorder.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Publication date: 2019

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Publication Year: 2019

Authors & Co-authors:  Stein Dan J DJ Khoo Jon-Paul JP Ahokas Antti A Jarema Marek M Van Ameringen Michael M Vavrusova Livia L Hӧschl Cyril C Bauer Michael M Bitter Istvan I Mosolov Sergey N SN